Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Whole genome sequencing of N. meningitidis leads to novel vaccine candidates

March 20, 2000

SangStat files NDA in Canada for Thymoglobulin

March 17, 2000

Isotechnika receives Canadian approval for human testing of immunosuppressive drug

March 16, 2000

3M's new immunomodulators induce TNF-alpha, IFN-alpha biosynthesis, inhibit Th2 immune response

March 15, 2000

Dynavax's ragweed immunotherapy has improved safety according to preclinical and clinical data

March 9, 2000

Prostanoid receptor ligands with selectivity for EP4 receptors designed by Ono researchers

March 9, 2000

White House teams up with industry to launch the Millennium Vaccine Initiative

March 9, 2000

Aerosol route preferred for measles vaccination campaign

March 7, 2000

Induction therapy with daclizumab in cardiac transplant recipients safe and effective

March 3, 2000

U.K.'s MCA approves another new meningitis C vaccine

March 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...